Cargando…

Validation of whole-blood transcriptome signature during microdose recombinant human erythropoietin (rHuEpo) administration

BACKGROUND: Recombinant human erythropoietin (rHuEpo) can improve human performance and is therefore frequently abused by athletes. As a result, the World Anti-Doping Agency (WADA) introduced the Athlete Biological Passport (ABP) as an indirect method to detect blood doping. Despite this progress, c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Guan, Durussel, Jérôme, Shurlock, Jonathan, Mooses, Martin, Fuku, Noriyuki, Bruinvels, Georgie, Pedlar, Charles, Burden, Richard, Murray, Andrew, Yee, Brendan, Keenan, Anne, McClure, John D., Sottas, Pierre-Edouard, Pitsiladis, Yannis P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5688496/ https://www.ncbi.nlm.nih.gov/pubmed/29143667 http://dx.doi.org/10.1186/s12864-017-4191-7

Ejemplares similares

rHuEPO Hyporesponsiveness and Related High Dosages Are Associated with Hyperviscosity in Maintenance Hemodialysis Patients
por: Erkmen Uyar, Mehtap, et al.
Publicado: (2013)

Darbepoetin alfa is more potent in vivo and can be administered less frequently than rHuEPO
por: Egrie, J, et al.
Publicado: (2002)

A Conjugated Aptamer-Gold Nanoparticle Fluorescent Probe for Highly Sensitive Detection of rHuEPO-α
por: Sun, Jiefang, et al.
Publicado: (2011)

Clinical study of Shengxuening tablet combined with rHuEPO for the treatment of renal anemia of maintenance hemodialysis patients
por: CHENG, XIN, et al.
Publicado: (2016)

Proof-of-concept study on improved efficacy of rHuEPO administered as a long-term infusion in rats
por: Szczesny, Damian, et al.
Publicado: (2020)

Asialo-rhuEPO as a Potential Neuroprotectant for Ischemic Stroke Treatment
por: Kittur, Farooqahmed S., et al.
Publicado: (2023)

Haemoglobin Mass and Running Time Trial Performance after Recombinant Human Erythropoietin Administration in Trained Men
por: Durussel, Jérôme, et al.
Publicado: (2013)

The Prevalence and Impact of Heavy Menstrual Bleeding (Menorrhagia) in Elite and Non-Elite Athletes
por: Bruinvels, Georgie, et al.
Publicado: (2016)

r.hu-Erythropoietin (EPO) treatment of pre-ESRD patients slows the rate of progression of renal decline
por: Tapolyai, Mihály, et al.
Publicado: (2003)

Genetic variants of erythropoietin (EPO) and EPO receptor genes in familial erythrocytosis
por: Vočanec, Danijela, et al.
Publicado: (2018)

Erythropoietin (EPO) in acute kidney injury
por: Moore, Elizabeth, et al.
Publicado: (2011)

Menstrual Cycle: The Importance of Both the Phases and the Transitions Between Phases on Training and Performance
por: Bruinvels, Georgie, et al.
Publicado: (2022)

Regulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study
por: Trincavelli, Maria Letizia, et al.
Publicado: (2013)

Comparison of Neurite Outgrowth Induced by Erythropoietin (EPO) and Carbamylated Erythropoietin (CEPO) in Hippocampal Neural Progenitor Cells
por: Oh, Dong Hoon, et al.
Publicado: (2012)

EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2018)

Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19?
por: Soliz, Jorge, et al.
Publicado: (2020)

Modelling menstrual cycle length in athletes using state-space models
por: de Paula Oliveira, Thiago, et al.
Publicado: (2021)

The hypoxia inducible factor/erythropoietin (EPO)/EPO receptor pathway is disturbed in a rat model of chronic kidney disease related anemia
por: Landau, Daniel, et al.
Publicado: (2018)

Human recombinant erythropoietin (rEpo) has no effect on tumour growth or angiogenesis
por: Hardee, M E, et al.
Publicado: (2005)

Better economy in field running than on the treadmill: evidence from high-level distance runners
por: Mooses, M, et al.
Publicado: (2015)

Erythropoietin (EPO)-receptor signaling induces cell death of primary myeloma cells in vitro
por: Våtsveen, Thea Kristin, et al.
Publicado: (2016)

Author Correction: EPO does not promote interaction between the erythropoietin and beta-common receptors
por: Cheung Tung Shing, Karen S., et al.
Publicado: (2019)

Hormonal Contraceptive Use in Football Codes in Australia
por: Clarke, Anthea C., et al.
Publicado: (2021)

Structural Identification of Modified Amino Acids on the Interface between EPO and Its Receptor from EPO BRP, Human Recombinant Erythropoietin by LC/MS Analysis
por: Song, Kwang-Eun, et al.
Publicado: (2014)

The Use of Technology to Protect the Health of Athletes During Sporting Competitions in the Heat
por: Muniz-Pardos, Borja, et al.
Publicado: (2019)

Huh-7 cell line as an alternative cultural model for the production of human like erythropoietin (EPO)
por: Kausar, Humera, et al.
Publicado: (2011)

Response Assessment to Erythropoietin-Zeta (Epo-Alpha Biosimilar) Therapy in Low-Risk Myelodysplastic Syndromes
por: Vetro, Calogero, et al.
Publicado: (2022)

Erythropoietin Receptor (EPOR) Signaling in the Osteoclast Lineage Contributes to EPO-Induced Bone Loss in Mice
por: Awida, Zamzam, et al.
Publicado: (2022)

Erythropoietin accelerates tumor growth through increase of erythropoietin receptor (EpoR) as well as by the stimulation of angiogenesis in DLD-1 and Ht-29 xenografts
por: Tankiewicz-Kwedlo, A., et al.
Publicado: (2016)

Comparative Study of Recombinant Human Erythropoietin (rhEPO) Products on CKD (Chronic Kidney Disease) Patients
por: Dwitanto, Kuspuji, et al.
Publicado: (2023)

Self-Rated Effectiveness of Microdosing With Psychedelics for Mental and Physical Health Problems Among Microdosers
por: Hutten, Nadia R. P. W., et al.
Publicado: (2019)

The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?
por: Lamon, Séverine, et al.
Publicado: (2013)

Erythropoietin (EPO) haplotype associated with all-cause mortality in a cohort of Italian patients with Type-2 Diabetes
por: Montesano, Alberto, et al.
Publicado: (2019)

The use of RNA‐based 5'‐aminolevulinate synthase 2 biomarkers in dried blood spots to detect recombinant human erythropoietin microdoses
por: Loria, Francesco, et al.
Publicado: (2021)

Epo/EpoR signaling in osteoprogenitor cells is essential for bone homeostasis and Epo-induced bone loss
por: Rauner, Martina, et al.
Publicado: (2021)

Microdosing: Concept, Application and Relevance
por: Tewari, Tushar, et al.
Publicado: (2010)

Asking questions of psychedelic microdosing
por: Cameron, Lindsay P
Publicado: (2021)

Generation of transgenic chickens expressing the human erythropoietin (hEPO) gene in an oviduct-specific manner: Production of transgenic chicken eggs containing human erythropoietin in egg whites
por: Kwon, Mo Sun, et al.
Publicado: (2018)

Methylation impact analysis of erythropoietin (EPO) Gene to hypoxia inducible factor-1α (HIF-1α) activity
por: Dewi, Firli Rahmah Primula, et al.
Publicado: (2013)

Effect of Roxadustat versus erythropoietin (EPO) for treating anemia in patients with diabetic kidney disease: a retrospective cohort study
por: Zhang, Lei, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_2i00slepj36utuo0k4o2q4i21k